Sheryl Kunning
- Immunology top 10%
- Immune Cell Function and Interaction 7
- Immunotherapy and Immune Responses 3
- Immune cells in cancer 2
- IL-33, ST2, and ILC Pathways 1
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 8
- CAR-T cell therapy research 2
- Otorhinolaryngology top 10%
-
- Cancer Genomics and Diagnostics 1
-
- Sarcoma Diagnosis and Treatment 1
- Co-authors
- Tullia C. BrunoDario A.A. VignaliAnthony R. CilloAyana T. RuffinRobert L. FerrisCaleb LampenfeldHuda I. AtiyaLan Coffman
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Sheryl Kunning
9 papers receiving 499 citations
Hit Papers
Peers
Comparison fields: 5 of 51
- Immunology 305
- Oncology 344
- Otorhinolaryngology 25
- Cancer Research 57
- Pulmonary and Respiratory Medicine 71
Countries citing papers authored by Sheryl Kunning
This map shows the geographic impact of Sheryl Kunning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheryl Kunning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheryl Kunning more than expected).
Fields of papers citing papers by Sheryl Kunning
This network shows the impact of papers produced by Sheryl Kunning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheryl Kunning. The network helps show where Sheryl Kunning may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sheryl Kunning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 24 | |
| 4 | Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunitybreakdown → | 2024 | 75 |
| 5 | LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunitybreakdown → | 2024 | 110 |
| 6 | 2023 | 16 | |
| 7 | 2022 | 18 | |
| 8 | 2022 | 25 | |
| 9 | B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinomabreakdown → | 2021 | 230 |
| 10 | 2019 | 1 |
About Sheryl Kunning
Sheryl Kunning is a scholar working on Immunology, Oncology and Otorhinolaryngology, having authored 10 papers that have together received 503 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (3 papers), CAR-T cell therapy research (2 papers), Immune cells in cancer (2 papers), IL-33, ST2, and ILC Pathways (1 paper), Sarcoma Diagnosis and Treatment (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Immunology (305 citations), Oncology (344 citations) and Otorhinolaryngology (25 citations). Sheryl Kunning has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Tullia C. Bruno, Dario A.A. Vignali, Anthony R. Cillo, Ayana T. Ruffin, Robert L. Ferris, Caleb Lampenfeld, Huda I. Atiya, Lan Coffman, Creg J. Workman and Seungwon Kim. Their work appears in journals such as Cell, Nature Communications and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.